Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.

Attempts to determine the extent and pattern of blood serum monitoring of mood stabilizers in Medicaid patients with bipolar disorder. Demographic and service use characteristics; Likelihood of therapeutic drug monitoring and case management services; Likelihood that lithium users will receive the recommended serum level test.